IVF USA Concierge - Peter18:22

Hello! I'm delighted to provide you with exclusive one-on-one consultation.
How can I assist you?

What is the process and cost of egg freezing?

Send
400-648-3872
Home service Medic honor Contact us

IVF USA Reveals: Why Do 70% of Infertility Patients Choose IVF-PGT in the United States?

2024-03-01 18:38:50,visits: 236


 

微信图片_20240301184035.png

According to a survey report from the Chinese Reproductive Health Expedition, the incidence of infertility among childbearing-age population in China is as high as 12%-15%, with a failure rate of treatment as high as 60%. With the opening of the two-child policy, more elderly people are seeking IVF treatment. Interestingly, when it comes to choosing IVF, 70% of infertility patients express a preference for undergoing surgery in the United States rather than domestically.

 

Why choose the United States?

 

First Reason: IVF-PGT Technology in the United States

 

The IVF technology in the United States is constantly innovating, evolving from the first generation to the third generation in just 40 years. Although the United States is not the birthplace of IVF technology, its medical technology updates rapidly. The third-generation technology screens and diagnoses embryos' chromosomes, selecting healthy embryos for transplantation, greatly improving the success rate of IVF.

 

Second Reason: Better Medical Conditions

 

After successfully extracting eggs and sperm, nurturing fertilized embryos is crucial. Compared to domestically only nurturing embryos for three days, the United States nurtures embryos for five days, significantly increasing the success rate after transplantation. The two-day difference requires extremely high laboratory conditions, and medical institutions in the United States invest a large amount of funds to build laboratories, far exceeding domestic technology levels.

 

Third Reason: More Rational Medication for Women

 

In IVF treatment, women are the focus. The United States avoids ovarian hyperstimulation syndrome caused by excessive medication and is more cautious about women's bodies. Compared to the excessive medication used domestically to obtain more eggs, the United States pays more attention to rational medication, avoiding additional troubles for women.

 

Fourth Reason: Legal Improvement

 

US law allows the selection of a child's gender during IVF transplantation, while China does not. In addition, in the United States, the LGBTQ+ community can obtain children through purchasing eggs and sperm or surrogacy, while in China, homosexuality is still illegal, let alone obtaining children through surrogacy.

 

For these reasons, 70% of patients chose the United States as their preferred location for IVF. When faced with infertility problems, choosing an IVF center with mature technology and superior medical conditions has become the wise choice for more and more patients.

微信图片_20240301184040.png

If you are facing infertility problems, IVF USA will be your solid backing. We are committed to providing professional and considerate IVF services to every patient, helping you achieve your dream of parenthood as soon as possible. Led by senior expert Dr. Nathan Zhang, our team will provide you with the highest quality medical services, leading you to a new starting point for fertility. Currently, IVF USA provides services such as egg freezing in the United States, IVF in the United States, and third-party assisted reproduction to those in need. Our business has expanded to include IVF and egg freezing in Japan, IVF and egg freezing in Thailand, as well as in Mexico, Taiwan, Hong Kong, and other regions, collaborating closely with top IVF doctors worldwide.

Choose IVF USA and let the flower of life bloom here!


Previous:Decoding the Lifespan of Eggs: Dr. Nathan Zhang from IVF USA Talks about American and Thai IVF-PGT Next:"Unveiling the Truth Behind Common Fertility Rumors: Coca-Cola, WiFi, and Hot Springs" IVF USA's Dr. Nathan Zhang Shares Insights on IVF-PGT
  • Copyright©1999-2016, sinamd.com All rights reserved. | ICP ID:沪ICP备16006508号-1
  • Shanghai ZhiTe Biotechnology Co., Ltd. All rights reserved. Phone: 400-648-3872

Shanghai Public Network Security No. 31011002004335